Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] ISU PETASYS (007660) – Submission of Audit Report / 2026-03-23

Posted on March 23, 2026August 1, 2026 By K-STOCK Editor No Comments on [Disclosure] ISU PETASYS (007660) – Submission of Audit Report / 2026-03-23

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ISU PETASYS submitted its Audit Report, receiving an ‘Unqualified’ audit opinion from external auditor Grant Thornton Daejoo for both its FY2025 consolidated and separate financial statements.

📊 [Key Disclosure Details & Financial Figures Summary]

  1. Auditor & Opinion
  • External Auditor: Grant Thornton Daejoo
  • Date of Audit Report Receipt: March 23, 2026
  • Audit Opinion (Consolidated & Separate): Unqualified
    • Uncertainties Related to Going Concern: N/A (Consolidated & Separate)
    • Uncertainties Related to Going Concern Unrelated to Audit Opinion: Unstated (Consolidated & Separate)
    • Internal Accounting Control System Opinion Unqualified Status: N/A (Separate)
    • Embezzlement/Malfeasance Disclosed in Report: No (Consolidated & Separate)
  1. Consolidated Financial Results
  • Total Assets: KRW 1,289,510,030,680 (KRW 1.29T) [Prior: KRW 790.14B]
  • Total Liabilities: KRW 533,312,849,236 (KRW 533.31B) [Prior: KRW 462.61B]
  • Total Equity: KRW 756,197,181,444 (KRW 756.20B) [Prior: KRW 327.53B]
  • Capital Stock: KRW 73,409,219,000 [Prior: KRW 63.25B]
  • Revenue: KRW 1,088,025,119,176 (KRW 1.09T) [Prior: KRW 836.87B]
  • Operating Profit: KRW 204,724,531,402 (KRW 204.72B) [Prior: KRW 101.88B]
  • Profit Before Income Taxes: KRW 201,694,461,225 [Prior: KRW 91.81B]
  • Net Profit: KRW 160,482,561,697 (KRW 160.48B) [Prior: KRW 74.03B]
  • Net Profit Attributable to Controlling Interest: KRW 160,481,952,837 [Prior: KRW 74.03B]
  • Number of Consolidated Subsidiaries: 6 (2 major subsidiaries)
  1. Separate Financial Results
  • Total Assets: KRW 1,187,846,761,986 [Prior: KRW 687.15B]
  • Total Liabilities: KRW 432,251,381,851 [Prior: KRW 356.90B]
  • Total Equity: KRW 755,595,380,135 [Prior: KRW 330.25B]
  • Revenue: KRW 929,664,876,365 [Prior: KRW 718.73B]
  • Operating Profit: KRW 152,138,714,730 [Prior: KRW 78.48B]
  • Net Profit: KRW 157,854,824,469 [Prior: KRW 65.25B]
  1. Other Details
  • Replaces the correction disclosure for the previously filed ‘Change in Revenue or Profit/Loss Structure of 30% (15% for Large Companies) or More’ on February 12, 2025
  • Financial statements in the audit report are subject to change during approval procedures at the Board of Directors or General Shareholders Meeting

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Confirmation of Unqualified Audit Opinion and Audited Financial Figures

This disclosure reports the filing of the FY2025 Audit Report, confirming that external auditor Grant Thornton Daejoo issued an ‘Unqualified’ opinion on both consolidated and separate financial statements. Verifying the receipt of an unqualified opinion and the audited figures is important for evaluating the accounting credibility of the company’s annual financial results and financial position. Detailed footnotes and finalized figures can be reviewed in the submitted FY2025 Audit Report and the Annual Report post shareholder meeting approval.

📢 Disclaimer and Source Notice

Source: This content was newly structured and created based on officially submitted data from the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Warning: This content is provided solely for informational and language reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities lie entirely with the individual investor.

Contact: For inquiries regarding compliance or copyright issues, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) to Sign KRW 2.22T Follow-up Contracts with Subsidiary to Execute Poland Chunmoo Project
Next Post: [Disclosure] Celltrion (068270) – Occurrence of Serious Industrial Accident / 2026-03-23

Related Posts

[Disclosure] Hanwha Ocean (042660) Announces Subsidiary Hanwha Ocean USA International LLC to Execute Paid-in Capital Increase of KRW 363.30B Disclosures
[Disclosure] Celltrion (068270) – Notice of Ex-Dividend Reference Price / 2024-12-26 Disclosures
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-04-28 Disclosures
[Disclosure] Hanwha Systems (272210) Signs KRW 124.8B Supply Contract with DAPA for KF-21 Initial Production AESA Radar and 12 Items Disclosures
[Disclosure] Hanwha Aerospace (012450) Subsidiary Files Amendment Revising Acquisition Value to KRW 870.5B for Singapore’s Dyna-Mac Disclosures
[Disclosure] Jusung Engineering (036930) – Sales and Supply Contract / 2024-07-10 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme